In Alzheimer disease (AD) research and care, novel biomarkers that measure amyloid-β (Aβ) and phosphorylated tau (P-tau)–the principal components of amyloid plaques and neurofibrillary tangles–have facilitated early detection and biomarker-supported diagnosis.1 Therapeutics that modify the biology...
Yeah, also read the abstract, it’s positive, but there are definite questions, the increase in ventricular volume was odd for one.
I just think we haven’t quite nailed the cause down yet, even if we’re close, there’s a wrinkle and trying to treat things we “almost understand” is risky (you can ‘cure’ some forms of mental illness with a lobotomy, but that’s not the point).